Dr. Maureen O'brien, M.D

NPI: 1710194881
Total Payments
$10,413
2024 Payments
$3,334
Companies
5
Transactions
10

Payment Breakdown by Category

Other$7,782 (74.7%)
Consulting$1,860 (17.9%)
Research$417.00 (4.0%)
Food & Beverage$353.93 (3.4%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $4,282 2 41.1%
Honoraria $3,500 1 33.6%
Consulting Fee $1,860 1 17.9%
Unspecified $417.00 1 4.0%
Food and Beverage $353.93 5 3.4%

Payments by Type

General
$9,996
9 transactions
Research
$417.00
1 transactions

Top Paying Companies

Company Total Records Latest Year
PFIZER INC. $6,700 2 $0 (2024)
JAZZ PHARMACEUTICALS INC. $1,985 2 $0 (2021)
Celgene Corporation $1,499 2 $0 (2018)
Amgen Inc. $133.76 1 $0 (2024)
Janssen Research & Development, LLC $94.99 3 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2024 $3,334 2 PFIZER INC. ($3,200)
2021 $1,860 1 JAZZ PHARMACEUTICALS INC. ($1,860)
2020 $3,500 1 PFIZER INC. ($3,500)
2019 $125.18 1 JAZZ PHARMACEUTICALS INC. ($125.18)
2018 $1,177 4 Celgene Corporation ($1,082)
2017 $417.00 1 Celgene Corporation ($417.00)

All Payment Transactions

10 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
12/10/2024 Amgen Inc. Blincyto (Biological) Food and Beverage In-kind items and services $133.76 General
Category: Oncology
06/05/2024 PFIZER INC. BESPONSA (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,200.00 General
Category: ONCOLOGY
01/18/2021 JAZZ PHARMACEUTICALS INC. RYLAZE (Drug) Consulting Fee Cash or cash equivalent $1,860.00 General
Category: HEMATOLOGY/ONCOLOGY
07/03/2020 PFIZER INC. BESPONSA (Biological) Honoraria Cash or cash equivalent $3,500.00 General
Category: ONCOLOGY
09/11/2019 JAZZ PHARMACEUTICALS INC. ERWINAZE (Drug) Food and Beverage In-kind items and services $125.18 General
Category: ONCOLOGY
10/05/2018 Janssen Research & Development, LLC DARZALEX (Drug) Food and Beverage In-kind items and services $50.00 General
Category: Oncology
10/05/2018 Janssen Research & Development, LLC DARZALEX (Drug) Food and Beverage In-kind items and services $30.00 General
Category: Oncology
10/05/2018 Janssen Research & Development, LLC DARZALEX (Drug) Food and Beverage In-kind items and services $14.99 General
Category: Oncology
06/13/2018 Celgene Corporation Revlimid (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $1,082.00 General
Category: Hematology / Oncology
10/30/2017 Celgene Corporation Revlimid (Drug) In-kind items and services $417.00 Research
Study: CC-5013-AML-002 • Category: Hematology / Oncology

Research Studies & Clinical Trials

Study Name Company Amount Records
CC-5013-AML-002 Celgene Corporation $417.00 1

About Dr. Maureen O'brien, M.D

Dr. Maureen O'brien, M.D is a Pediatric Hematology-Oncology healthcare provider based in Aurora, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2007. The National Provider Identifier (NPI) number assigned to this provider is 1710194881.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Maureen O'brien, M.D has received a total of $10,413 in payments from pharmaceutical and medical device companies, with $3,334 received in 2024. These payments were reported across 10 transactions from 5 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($4,282).

Practice Information

  • Specialty Pediatric Hematology-Oncology
  • Other Specialties Pediatric Hematology-Oncology
  • Location Aurora, CO
  • Active Since 05/17/2007
  • Last Updated 11/16/2023
  • Taxonomy Code 2080P0207X
  • Entity Type Individual
  • NPI Number 1710194881

Products in Payments

  • BESPONSA (Biological) $6,700
  • RYLAZE (Drug) $1,860
  • Revlimid (Drug) $1,499
  • Blincyto (Biological) $133.76
  • ERWINAZE (Drug) $125.18
  • DARZALEX (Drug) $94.99

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatric Hematology-Oncology Doctors in Aurora